Merck & Co. to Buy Idenix for $3.9 Billion for Hepatitis C Drugs
Alert: HALISTER Source: BN (Bloomberg News)
Tickers MRK US (Merck & Co Inc) IDIX US (Idenix Pharmaceuticals Inc) 1147L US (Sullivan & Cromwell LLP)
Topics Viral Hepatitis Viral Illnesses
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283